Product
ChAdOx2 RabG
1 clinical trial
1 indication
Indication
RabiesClinical trial
A Phase Ib/II Age De-escalation, Dose Escalation, Partially Randomised, Open-label Head-to-head Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabGStatus: Active (not recruiting), Estimated PCD: 2028-09-01